Evidence map›Paper›PMID 39392881›Full record

ArticleScience advances2024

Shank3 mutation impairs glutamate signaling and myelination in ASD mouse model and human iPSC-derived OPCs.

Inbar Fischer, Sophie Shohat, Yael Leichtmann-Bardoogo, Ritu Nayak, Gal Wiener, Idan Rosh, Aviram Shemen, Utkarsh Tripathi, May Rokach, Ela Bar and 12 more

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Inbar FischerThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.ORCID 0009-0005-4915-2114
Sophie ShohatThe School of Psychological Sciences, Faculty of Social Sciences, Tel Aviv University, Tel Aviv, Israel.
Yael Leichtmann-BardoogoDepartment of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0003-1130-5064
Ritu NayakSagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Gal WienerThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Idan RoshSagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.
Aviram ShemenSagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.ORCID 0009-0001-0493-9803
Utkarsh TripathiSagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.ORCID 0000-0001-9503-3793
May RokachThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.ORCID 0009-0009-9226-7653
Ela BarThe School of Psychological Sciences, Faculty of Social Sciences, Tel Aviv University, Tel Aviv, Israel.
Yara HusseinSagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.ORCID 0000-0001-6173-8584
Ana Carolina CastroDepartment of Biomedicine-Experimental Biology Unit, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal.ORCID 0009-0007-4430-163X
Gal ChenThe Louis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion, Haifa, Israel.
Adi SofferDepartment of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.
Sari Schokoroy-TrangleThe School of Psychological Sciences, Faculty of Social Sciences, Tel Aviv University, Tel Aviv, Israel.
Galit Elad-SfadiaThe School of Psychological Sciences, Faculty of Social Sciences, Tel Aviv University, Tel Aviv, Israel.
Yaniv AssafThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Avi SchroederThe Louis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion, Haifa, Israel.ORCID 0000-0003-2571-5937
Patricia MonteiroDepartment of Biomedicine-Experimental Biology Unit, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal.ORCID 0000-0003-3288-4560
Shani SternSagol Department of Neurobiology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel.ORCID 0000-0002-2644-7068
Ben M MaozThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0002-3823-7682
Boaz BarakThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0001-9724-4578

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is characterized by social and neurocognitive impairments, with mutations of the

Indexed as

Autism Spectrum DisorderDisease Models, AnimalGlutamic AcidInduced Pluripotent Stem CellsMutationMyelin SheathNerve Tissue ProteinsOligodendrogliaSignal TransductionAnimalsHumansMiceMicrofilament ProteinsGlutamic AcidMicrofilament ProteinsNerve Tissue ProteinsSHANK3 protein, humanShank3 protein, mouse

Identifiers

PMID39392881
PMCPMC11468907

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.